other:Article Title: Orientia tsutsugamushi modulates p53, the cell cycle, and genotoxicity to maintain its intracellular niche.
Article Snippet: Primary antibodies used were: mouse anti-p53 (Santa Cruz [sc-98]; 1:200), rabbit anti-p21 (Cell Signaling [#2947]; 1:1000), mouse anti-HDM2 (Invitrogen [#33-7100]; 1:500), mouse anti-Cyclin E (Santa Cruz, Dallas, TX [sc-377100]; 1:500), mouse anti-Cyclin A (Santa Cruz [sc-271682]; 1:250), mouse anti-Cyclin D3 (Cell Signaling, Danvers, MA [#2936]; 1:1000), rabbit anti-Cyclin D1 (Cell Signaling [#55506]; 1:1000), rabbit anti-Cyclin B1 (Cell Signaling [#4138]; 1:1000), rabbit anti-TCF11/NRF1 (Cell Signaling [#8052]; 1:1000), rabbit anti-GFP (Invitrogen [A11122]; 1:1000), rabbit antiGMNN (Cell Signaling [#52508]; 1:1000), rabbit anti-cdc25a (Cell Signaling [#3652]; 1:1000), rabbit anti-phosphorylated-Histone H2A.X (ƔH2AX) (Cell Signaling [#2577]; 1:1,1000), rabbit anti-Caspase 7 (Cell Signaling [#9492]; 1:1000), rabbit anti-Caspase 3 (Cell Signaling [#9662]; 1:1000), rabbit anti-PARP1 (Invitrogen [MA5-15031]; 1:1000), rabbit anti-PKR (Cell signaling [#3072; 1:1000), rabbit anti-p-PKR (T446) (Abcam [ab32036]; 1:1000), rabbit anti-O. tsutsugamushi TSA56123 (1:1000), mouse anti-GAPDH (Santa Cruz [sc-365062]; 1:750).
Article Title: Orientia tsutsugamushi modulates p53, the cell cycle, and genotoxicity to maintain its intracellular niche
Article Snippet: Primary antibodies used were: mouse anti-p53 (Santa Cruz [sc-98]; 1:200), rabbit anti-p21 (Cell Signaling [#2947]; 1:1000), mouse anti-HDM2 (Invitrogen [#33-7100]; 1:500), mouse anti-Cyclin E (Santa Cruz, Dallas, TX [sc-377100]; 1:500), mouse anti-Cyclin A (Santa Cruz [sc-271682]; 1:250), mouse anti-Cyclin D3 (Cell Signaling, Danvers, MA [#2936]; 1:1000), rabbit anti-Cyclin D1 (Cell Signaling [#55506]; 1:1000), rabbit anti-Cyclin B1 (Cell Signaling [#4138]; 1:1000), rabbit anti-TCF11/NRF1 (Cell Signaling [#8052]; 1:1000), rabbit anti-GFP (Invitrogen [A11122]; 1:1000), rabbit anti-GMNN (Cell Signaling [#52508]; 1:1000), rabbit anti-cdc25a (Cell Signaling [#3652]; 1:1000), rabbit anti-phosphorylated-Histone H2A.X (ƔH2AX) (Cell Signaling [#2577]; 1:1,1000), rabbit anti-Caspase 7 (Cell Signaling [#9492]; 1:1000), rabbit anti-Caspase 3 (Cell Signaling [#9662]; 1:1000), rabbit anti-PARP1 (Invitrogen [MA5-15031]; 1:1000), rabbit anti-PKR (Cell signaling [#3072; 1:1000), rabbit anti-p-PKR (T446) (Abcam [ab32036]; 1:1000), rabbit anti- O. tsutsugamushi TSA56 (1:1000), mouse anti-GAPDH (Santa Cruz [sc-365062]; 1:750).
Article Title: Targeting of HIF2-driven cachexia in kidney cancer
Article Snippet: The primary antibodies used included: rabbit anti-cyclin D1 (Cell Signaling Technologies, cat. no. 2978), rabbit anti-HIF2α (D6T8V; Cell Signaling Technology, cat. no. 29973S), rabbit anti-NDRG1 (Cell Signaling Technology, cat. no. 5196S), mouse anti-vinculin (Sigma, cat. no. V9131), rabbit anti-V5-tag (Cell Signaling Technology, cat. no. 13202S), mouse anti-β-actin (Cell Signaling Technology, cat. no. 3700S), anti-streptavidin–HRP (Cell Signaling Technology, cat. no. 3999S), rabbit anti-IGFBP3 (Cell Signaling Technology, cat. no. 25864S) and rabbit anti-MMP2 (D2O4T; Cell Signaling Technology, cat. no. 87809S).
Article Title: ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma.
Article Snippet: The prognosis of pancreatic adenocarcinoma remains dismal up to now, partly owing to a lack of clinically feasible therapeutic targets.. ARHGAP11A, a member of Rho GTPase-activating proteins family, has been reported as a prognostic biomarker and oncogene for multiple cancers.. However, the specific effects of ARHGAP11A in pancreatic adenocarcinoma remain obscure.
Article Title: Dysregulation of xenobiotic metabolism and mitochondrial dysfunction exacerbate acetaminophen-induced hepatotoxicity in human antigen R-deficient male mice
Article Snippet: Primary antibodies included rabbit anti-AIF (CST, 4642S), rabbit anti-Bax (CST, 2772S), rabbit anti-Smac (CST, D5S3R), mouse anti-HuR (Santa Cruz, sc-5261), rabbit anti-Cyp2e1 (Abcam, Ab28146), rabbit anti-pJNK (CST, 4668P), rabbit anti-JNK (CST, 9252T), rabbit anti-Caspase-3 (CST, 9665), rabbit anti-cyclin D1 (CST, 2978S), mouse anti-GAPDH (Sigma, G8795), mouse anti-α-tubulin (Sigma, T6199), mouse anti-β-actin (Sigma, A2228), and rabbit anti-VDAC (CST, D73D12).
Article Title: Targeting of HIF2-driven cachexia in kidney cancer.
Article Snippet: The primary antibodies used included: rabbit anti-cyclin D1 (Cell Signaling Technologies, cat. no. 2978), rabbit anti-HIF2α (D6T8V; Cell Signaling Technology, cat. no. 29973S), rabbit anti-NDRG1 (Cell Signaling Technology, cat. no. 5196S), mouse anti-vinculin (Sigma, cat. no. V9131), rabbit anti-V5-tag (Cell Signaling Technology, cat. no. 13202S), mouse anti-β-actin (Cell Signaling Technology, cat. no. 3700S), anti-streptavidin–HRP (Cell Signaling Technology, cat. no. 3999S), rabbit anti-IGFBP3 (Cell Signaling Technology, cat. no. 25864S) and rabbit anti-MMP2 (D2O4T; Cell Signaling Technology, cat. no. 87809S).
Article Title: SLC4A11 is a targetable marker correlated with therapeutic responses in ovarian cancer
Article Snippet: The primary antibodies used in the study were: rabbit anti-Cyclin D1 (1:2000 dilution, Cat# 2922, RRID: AB_2228523) and rabbit anti-Cyclin E1 (1:2000 dilution, Cat# 20808, RRID: AB_2783554) from Cell Signaling Technology, Inc. (Danvers, MA, USA); rabbit anti-SLC4A11/BTR1 (1:500 dilution, Cat# ARG67022 , RRID: AB_3096966) from Arigo Biolaboratories Corp. (Zhubei City, Hsinchu County, Taiwan, China); mouse anti-β-ACTIN (1:5000 dilution, Cat# 66009-1-Ig, RRID: AB_2687938) from Proteintech Group, Inc. (Wuhan, China).
|